Ginkgo Bioworks Granted U.S. Patent #11702665: Paenibacillus-based endospore display platform, products and methods
Portfolio Pulse from Charles Gross
Ginkgo Bioworks has been granted U.S. Patent #11702665 for a Paenibacillus-based endospore display platform, products, and methods. This new patent could potentially enhance the company's product offerings and competitive edge in the biotech industry.
July 18, 2023 | 6:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ginkgo Bioworks' new patent could potentially enhance their product offerings and competitive edge in the biotech industry. This could have a positive impact on the company's stock.
The granting of a new patent to Ginkgo Bioworks could potentially enhance their product offerings and competitive edge in the biotech industry. This could lead to increased revenues and profitability, which would likely have a positive impact on the company's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100